CommonSpirit CEO Lloyd Dean to retire next year
The announcement sets off a search for his successor as the organization heads into its third full fiscal year.
The announcement sets off a search for his successor as the organization heads into its third full fiscal year.
The agency gave the designation to Quanterix’s blood test, which has the potential to aid evaluation of people who present with cognitive impairment, and Nonagen Bioscience’s non-invasive bladder cancer test.
It’s the third healthcare buy for the Minneapolis-based consumer electronics giant, as the company looks to capitalize on trends like the aging population and rising demand for lower-cost care.
The deal with Compass Surgical Partners builds on the hospital operator’s long-term strategy of expanding that line.
The British drugmaker could soon become the first with both a marketed vaccine and treatment for COVID-19, a notable achievement. Yet competition has blunted the potential impact of each of them.
Despite broad bipartisan support for telehealth in Washington, the return of restrictions — even nominal ones — threaten the viability of virtual services offered by cash-strapped primary care offices, a new survey finds.
The two partners have officially filed for emergency authorization of their antiviral pill, a milestone in the fight against COVID-19. It’s not yet clear whether vaccine recipients will be eligible for treatment, however.
About 90% of people currently enrolled in MA plans offering prescription drug coverage are enrolled in a plan that will earn four stars in 2022.
The outcome does not mean a strike will start immediately. The results give union leaders the authority to set a strike date so long as they give the required 10-day notice in writing to Kaiser Permanente.
Learn what’s changed and how you can leverage technology and data to shape the healthcare of tomorrow.